Please use this identifier to cite or link to this item:
Title: Dietary whey protein lessens several risk factors for metabolic diseases: a review
Authors: Sousa, Gabriela T. D.
Lira, Fabio Santos de
Rosa, Jose C.
Oliveira, Erick P. de
Oyama, Lila Missae [UNIFESP]
Santos, Ronaldo Vagner Thomatieli dos [UNIFESP]
Pimentel, Gustavo Duarte
Universidade Estadual de Campinas (UNICAMP)
Universidade de São Paulo (USP)
Univ Extremo Catarinense
Universidade Federal de São Paulo (UNIFESP)
Keywords: Whey protein
Type 2 diabetes mellitus
Issue Date: 7-Jun-2012
Publisher: Biomed Central Ltd
Citation: Lipids in Health and Disease. London: Biomed Central Ltd, v. 11, 9 p., 2012.
Abstract: Obesity and type 2 diabetes mellitus (DM) have grown in prevalence around the world, and recently, related diseases have been considered epidemic. Given the high cost of treatment of obesity/DM-associated diseases, strategies such as dietary manipulation have been widely studied; among them, the whey protein diet has reached popularity because it has been suggested as a strategy for the prevention and treatment of obesity and DM in both humans and animals. Among its main actions, the following activities stand out: reduction of serum glucose in healthy individuals, impaired glucose tolerance in DM and obese patients; reduction in body weight; maintenance of muscle mass; increases in the release of anorectic hormones such as cholecystokinin, leptin, and glucagon like-peptide 1 (GLP-1); and a decrease in the orexigenic hormone ghrelin. Furthermore, studies have shown that whey protein can also lead to reductions in blood pressure, inflammation, and oxidative stress.
ISSN: 1476-511X
Other Identifiers:
Appears in Collections:Resenha

Files in This Item:
File Description SizeFormat 
WOS000306374900002.pdf606.37 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.